Hint mode is switched on Switch off
For swift navigation between sections

Roivant Sciences
LEI 549300DL466NY5J6U724

PDF download

Choose all Reset all
Download Cancel
Organization name
Roivant Sciences Ltd.
Country name
Bermuda
Country of registration
Bermuda
Industry
Pharmaceutical Preparation and Biotechnology
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Roivant Sciences Ltd. operates as a healthcare company. The Company offers investigational drugs in development for therapeutic areas such as dermatology, immunology, and respiratory diseases, as well as provides healthcare technologies which help healthcare institutions share and aggregate data. Roivant Sciences provides services worldwide.

Awards

News

05/03/2026 Roivant Sciences Ltd. (NASDAQ:ROIV) Maintains "Buy" Rating Amid Positive Momentum
03/03/2026 Roivant Sciences: Entry Into A Material Definitive Agreement, Regulation Fd Disclosure, Other Information, Financial Statements And Exhibits
18/09/2025 Roivant Sciences (NASDAQ:ROIV) Stock Update and Phase 3 VALOR Study Results
10/09/2025 Roivant Sciences: Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
03/09/2025 Roivant Sciences: Regulation Fd Disclosure, Other Events, Financial Statements And Exhibits
All organization news

Documentation

IFRS/US GAAP reports

2026
I q eng
2025
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
II q eng
III q eng
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    549300DL466NY5J6U724
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0001635088
  • EIN
    98-1173944
Registration is required to get access.